These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2334412)

  • 61. Ligand size as a determinant for catabolism by the low density lipoprotein (LDL) receptor pathway. A lattice model for LDL binding.
    Chappell DA; Fry GL; Waknitz MA; Berns JJ
    J Biol Chem; 1991 Oct; 266(29):19296-302. PubMed ID: 1918046
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation.
    Innerarity TL; Weisgraber KH; Arnold KS; Rall SC; Mahley RW
    J Biol Chem; 1984 Jun; 259(11):7261-7. PubMed ID: 6327714
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Apolipoprotein E-binding proteins isolated from dog and human liver.
    Beisiegel U; Weber W; Havinga JR; Ihrke G; Hui DY; Wernette-Hammond ME; Turck CW; Innerarity TL; Mahley RW
    Arteriosclerosis; 1988; 8(3):288-97. PubMed ID: 2835955
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatic apolipoprotein and LDL receptor gene expression in the genetically hypercholesterolemic (RICO) rat.
    Felgines C; Sérougne C; Mazur A; Férézou J; Lutton C; Rayssiguier Y
    Atherosclerosis; 1995 Sep; 117(1):15-24. PubMed ID: 8546751
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lipid metabolism and glial lipoproteins in the central nervous system.
    Hayashi H
    Biol Pharm Bull; 2011; 34(4):453-61. PubMed ID: 21467629
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E.
    Wilson C; Wardell MR; Weisgraber KH; Mahley RW; Agard DA
    Science; 1991 Jun; 252(5014):1817-22. PubMed ID: 2063194
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Genetic mutants of plasma apolipoprotein E--apo E-5 and apo E-Suita--associated with hyperlipidemia and atherosclerosis].
    Yamamura T; Yokoyama S; Yamamoto A; Sumiyoshi T; Hiramori K; Nishioeda Y; Tsushima M; Nambu S; Ikeda M
    Nihon Naika Gakkai Zasshi; 1985 Jan; 74(1):62-9. PubMed ID: 3998580
    [No Abstract]   [Full Text] [Related]  

  • 68. Characterisation and mode of inheritance of apolipoprotein E3-Leiden.
    Havekes L; Utermann G; de Knijff P; Klasen E
    Adv Exp Med Biol; 1987; 210():41-5. PubMed ID: 3591555
    [No Abstract]   [Full Text] [Related]  

  • 69. Cell-released substances interfere with low density lipoprotein receptor determination in fibroblasts.
    Leren TP; Berg K
    Scand J Clin Lab Invest; 1985 Jun; 45(4):379-85. PubMed ID: 4012217
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity.
    Wardell MR; Rall SC; Schaefer EJ; Kane JP; Weisgraber KH
    J Lipid Res; 1991 Mar; 32(3):521-8. PubMed ID: 1648586
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of the human apolipoprotein E gene in cultured mammalian cells.
    Reardon CA; Lau YF; Paik YK; Weisgraber KH; Mahley RW; Taylor JM
    J Biol Chem; 1986 Jul; 261(21):9858-64. PubMed ID: 3733697
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human placental microvilli as a source of antigen for the preparation of a polyclonal antibody directed against the LDL receptor.
    Goldstein S; Moreau M; Barbu V; Meier M; Alsat E; Mazière C; Mazière JC; Polonovski J
    Biochimie; 1989 Mar; 71(3):379-82. PubMed ID: 2500986
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Two mutant low-density-lipoprotein receptors in Afrikaners slowly processed to surface forms exhibiting rapid degradation or functional heterogeneity.
    Fourie AM; Coetzee GA; Gevers W; van der Westhuyzen DR
    Biochem J; 1988 Oct; 255(2):411-5. PubMed ID: 3202825
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Koch's postulates for cholesterol.
    Brown MS; Goldstein JL
    Cell; 1992 Oct; 71(2):187-8. PubMed ID: 1423585
    [No Abstract]   [Full Text] [Related]  

  • 75. Analytical procedures for the detection and characterization of apolipoprotein E mutants.
    Assmann G; Funke H; Jabs HU
    Am Heart J; 1987 Feb; 113(2 Pt 2):598-603. PubMed ID: 3544776
    [No Abstract]   [Full Text] [Related]  

  • 76. Hyperlipidaemia and cardiovascular disease.
    Dominiczak MH
    Curr Opin Lipidol; 2002 Jun; 13(3):343-5. PubMed ID: 12045405
    [No Abstract]   [Full Text] [Related]  

  • 77. Genetics and molecular biology.
    Ikonen E
    Curr Opin Lipidol; 2003 Apr; 14(2):219-21. PubMed ID: 12642790
    [No Abstract]   [Full Text] [Related]  

  • 78. Measuring diffusion coefficients of labelled particles on cell surfaces by digital fluorescence microscopy.
    Morrison IE; Anderson CM; Georgiou GN; Cherry RJ
    Biochem Soc Trans; 1990 Oct; 18(5):938. PubMed ID: 2083748
    [No Abstract]   [Full Text] [Related]  

  • 79. May 2020 (vol. 222, no. 5, pages 489.e1, .e3-.e5, .e7).
    Am J Obstet Gynecol; 2023 Jan; 228(1):125-128. PubMed ID: 34740415
    [No Abstract]   [Full Text] [Related]  

  • 80. September 2017 (vol. 217, no. 3, page 346.e5).
    Am J Obstet Gynecol; 2018 Aug; 219(2):198. PubMed ID: 29397909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.